Effector Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Effector Therapeutics (EFTRW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Effector Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Effector Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Effector Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $102 | 1.4k | 0.07 |
2023-06-30 | $2.7k | 20k | 0.14 |
2022-06-30 | $999 | 2.9k | 0.34 |
2022-03-31 | $1.0k | 3.0k | 0.33 |
2021-12-31 | $1.0k | 795 | 1.26 |
2021-09-30 | $2.0k | 1.2k | 1.63 |